Send us a text

This conversation is centered on Marcelo Kugelmas's portion of Madrigal's disease-focused presentation at the Chronic Liver Disease Foundation's LiverConnect meeting this past March in Scottsdale, AZ. Marcelo addresses issues of NAFLD patient screening and NASH patient management. Afterwards, he answers questions and reviews key elements of the presentation with Roger Green. Finally, Roger interviews Dr. Naim Alkhouri on the patient prevalence implications of the San Antonio Military Medical Study (2021), of which he was an author, and on the strategies, he uses to bring patients into his practice to be screened (think "Free FibroScan" for the curious.)

This episode and all its conversations are sponsored by Madrigal Pharmaceuticals. Conversations 25.5 and 25.6 are a two-part summary of Madrigal's disease-focused presentation at the recent CLDF LiverConnect meeting.